Spruce Biosciences (SPRB) Stock Chart & Stock Price History $0.07 0.00 (-3.61%) As of 06/13/2025 03:22 PM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Spruce Biosciences Stock Price Performance The Spruce Biosciences (SPRB) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 88.50%, with a year-to-date return of -82.21%. In the past month, the stock has increased 20.48%, reflecting recent market activity. As of the latest close, Spruce Biosciences traded at $0.07 with a market cap of $3.16 million and volume of 196,343 shares. Receive SPRB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Spruce Biosciences and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+24.50%1 Month Performance+20.48%3 Month Performance-77.71%Year-To-Date Performance-82.21%1 Year Performance-88.50% SPRB Stock Chart for Saturday, June, 14, 2025 SPRB Chart by TradingView Spruce Biosciences Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/13/2025$0.08$0.07-3.61%$0.08$0.07196,343 shs$3.16 million06/12/2025$0.06$0.08+27.05%$0.09$0.081.40 million shs$3.27 million06/11/2025$0.07$0.06-6.15%$0.06$0.0673,825 shs$2.58 million06/10/2025$0.06$0.07+8.33%$0.07$0.06280,336 shs$2.75 million06/09/2025$0.06$0.06-6.10%$0.07$0.061.29 million shs$2.53 million06/06/2025$0.07$0.06-1.69%$0.06$0.0624,829 shs$2.70 million06/05/2025$0.06$0.07+7.97%$0.07$0.0631,386 shs$2.75 million06/04/2025$0.07$0.06-7.38%$0.07$0.06312,472 shs$2.54 million06/03/2025$0.06$0.07+1.88%$0.07$0.06385,207 shs$2.75 million06/02/2025$0.07$0.06-8.60%$0.07$0.06350,080 shs$2.69 million Get the Latest News and Ratings for SPRB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Spruce Biosciences and its competitors with MarketBeat's FREE daily newsletter. 05/30/2025$0.07$0.07+0.43%$0.07$0.07223,611 shs$2.95 million05/29/2025$0.06$0.07+8.59%$0.07$0.06245,879 shs$2.94 million05/28/2025$0.06$0.06-1.39%$0.07$0.0613,882 shs$2.70 million05/27/2025$0.06$0.06+3.02%$0.06$0.0695,034 shs$2.74 million05/26/2025$0.06$0.06$0.06$0.0653,081 shs$2.66 million05/23/2025$0.06$0.06+4.30%$0.06$0.0653,081 shs$2.66 million05/22/2025$0.06$0.06-4.13%$0.06$0.0624,865 shs$2.55 million05/21/2025$0.06$0.06-2.93%$0.06$0.0630,922 shs$2.66 million05/20/2025$0.06$0.06+0.15%$0.06$0.0694,867 shs$2.74 million05/19/2025$0.06$0.06-0.15%$0.07$0.06289,648 shs$2.74 million05/16/2025$0.07$0.06-1.52%$0.07$0.0691,932 shs$2.74 million05/15/2025$0.06$0.07+6.29%$0.07$0.06270,558 shs$2.78 million05/14/2025$0.07$0.06-5.34%$0.07$0.06162,428 shs$2.62 million05/13/2025$0.07$0.07-9.03%$0.07$0.06252,950 shs$2.77 million Related Companies Cyclerion Therapeutics Stock Chart NLS Pharmaceutics Stock Chart Kiora Pharmaceuticals Stock Chart AEON Biopharma Stock Chart Brainstorm Cell Therapeutics Stock Chart Carisma Therapeutics Stock Chart Moleculin Biotech Stock Chart Dogwood Therapeutics Stock Chart Lakeshore Biopharma Stock Chart Traws Pharma Stock Chart Receive SPRB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Spruce Biosciences and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:SPRB) was last updated on 6/14/2025 by MarketBeat.com Staff From Our PartnersThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredGet in stocks now - and get out on this dateGood News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history giv...Chaikin Analytics | Sponsored[First Look] Get in before potential 10X AI announcementsGo for 10X gains from the next big AI announcement — starting as soon as 7 days from now Former floor trade...Masters in Trading | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | SponsoredSHOCKING: Musk's Pentagon Secret Mission...It's about a harrowing message discovered on December 16, 2024: "美国军方暗杀名单" It's the reason President Tru...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Spruce Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Spruce Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.